Cargando…

Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy

Basic research on human pluripotent stem cell (hPSC)‐derived cardiomyocytes (CMs) for cardiac regenerative therapy is one of the most active and complex fields to achieve this alternative to heart transplantation and requires the integration of medicine, science, and engineering. Mortality in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morita, Yuika, Kishino, Yoshikazu, Fukuda, Keiichi, Tohyama, Shugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357358/ https://www.ncbi.nlm.nih.gov/pubmed/35534945 http://dx.doi.org/10.1111/cpr.13248

Ejemplares similares

The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
por: Soma, Yusuke, et al.
Publicado: (2021)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021)

Toward the realization of cardiac regenerative medicine using pluripotent stem cells
por: Kishino, Yoshikazu, et al.
Publicado: (2020)

Metabolic Regulation of Cardiac Differentiation and Maturation in Pluripotent Stem Cells: A Lesson from Heart Development
por: Morita, Yuika, et al.
Publicado: (2020)

Seamless and non-destructive monitoring of extracellular microRNAs during cardiac differentiation from human pluripotent stem cells
por: Sekine, Otoya, et al.
Publicado: (2023)

Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes
por: Tohyama, Shugo, et al.
Publicado: (2017)

Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells
por: Seki, Tomohisa, et al.
Publicado: (2014)

Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells
por: Someya, Shota, et al.
Publicado: (2021)

Purification of cardiomyocytes and neurons derived from human pluripotent stem cells by inhibition of de novo fatty acid synthesis
por: Tanosaki, Sho, et al.
Publicado: (2022)

Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells
por: Tanosaki, Sho, et al.
Publicado: (2020)

Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions
por: Kishino, Yoshikazu, et al.
Publicado: (2014)

Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application
por: Tohyama, Shugo, et al.
Publicado: (2017)

Protocol for enhanced proliferation of human pluripotent stem cells in tryptophan-fortified media
por: Kameda, Kotaro, et al.
Publicado: (2022)

Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
por: Kishino, Yoshikazu, et al.
Publicado: (2023)

Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin
por: Tanaka, Yuki, et al.
Publicado: (2023)

Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
por: Silver, Sophia E., et al.
Publicado: (2021)

Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions
por: Kishino, Yoshikazu, et al.
Publicado: (2015)

An effective detachment system for human induced pluripotent stem cells cultured on multilayered cultivation substrates using resonance vibrations
por: Terao, Yusuke, et al.
Publicado: (2019)

Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction
por: Nakajima, Kazuaki, et al.
Publicado: (2015)

Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair
por: Dunn, Kaitlin K., et al.
Publicado: (2018)

A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
por: Lin, Haishuang, et al.
Publicado: (2018)

Automated Deep Learning-Based System to Identify Endothelial Cells Derived from Induced Pluripotent Stem Cells
por: Kusumoto, Dai, et al.
Publicado: (2018)

Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo
por: Kawai, Yujiro, et al.
Publicado: (2022)

Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies
por: Jenkins, Michael J, et al.
Publicado: (2015)

Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
por: Ogi, Derek A., et al.
Publicado: (2023)

In vivo multi-modality tracking of the regenerative effects of the human induced pluripotent stem cell-derived cardiomyocytes (iCMs)
por: Mahmoudi, Morteza, et al.
Publicado: (2015)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes
por: Chu, Axel J., et al.
Publicado: (2020)

Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication
por: Fukuda, Keiichi
Publicado: (2023)

Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression
por: Uosaki, Hideki, et al.
Publicado: (2011)

Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin‐Free Medium, Enabling Consistent Manufacture of Cardiomyocytes
por: Lin, Yongshun, et al.
Publicado: (2016)

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatment
por: Tan, Lay Shuen, et al.
Publicado: (2022)

Gata6 in pluripotent stem cells enhance the potential to differentiate into cardiomyocytes
por: Yoon, Chang-Hwan, et al.
Publicado: (2018)

Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes
por: Saito, Yukihiro, et al.
Publicado: (2022)

Induced Pluripotent Stem Cell-Derived Cardiac Progenitors Differentiate to Cardiomyocytes and Form Biosynthetic Tissues
por: Christoforou, Nicolas, et al.
Publicado: (2013)

Time-regulated transcripts with the potential to modulate human pluripotent stem cell-derived cardiomyocyte differentiation
por: Muñoz, Juan J. A. M., et al.
Publicado: (2022)

Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture
por: Kempf, Henning, et al.
Publicado: (2014)

Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture
por: Olmer, Ruth, et al.
Publicado: (2018)

Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes
por: Liu, Jianwei, et al.
Publicado: (2012)

Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge
por: Aigha, Idil, et al.
Publicado: (2016)

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lbrje80i47jcrbv9c5lq2etp0d